Descallar, Rene S.

HRN: 23-98-23  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/26/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
07/26/2025
08/02/2025
IV
500mg
Q8H
Partial Bowel Obstruction Prob Sec To Post Op Adhesions
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: